ReviewThe American psychologist2018
The role of psychological science in efforts to improve cardiovascular medication adherence.
Review in The American psychologist, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.
- Psychological determinants of medication adherence in patients with hypertension: a systematic review and meta‑analysis.Journal of behavioral medicine · 2026Pooled it
- Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation.The Cochrane database of systematic reviews · 2024Pooled it
- Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial.BMC cardiovascular disorders · 2021Trial
- Overcoming Psychological Barriers to Treatment Adherence: The Case of Antihypertensive Medication.Cardiology clinics · 2026Review
- Adherence to Pharmacological Therapy for Hypertension in Portugal: Insights from Patients' Focus Groups.Patient preference and adherence · 2026Article
- Devastating impact of performance-enhancing drugs: a case of severe heart failure in a young bodybuilder with bodydysmo rphic disorder.The British journal of cardiology · 2025Article
- Examining the influence of anxiety and depression on medication adherence among patients diagnosed with acute myocardial infarction.BMC psychology · 2024Article
- Temporal characteristics and associated factors of discontinuation and outcomes after percutaneous coronary intervention.Frontiers in pharmacology · 2024Article
- Positivity and Health Locus of Control: Key Variables to Intervene on Well-Being of Cardiovascular Disease Patients.Journal of personalized medicine · 2023Article
- Development of metaverse for intelligent healthcare.Nature machine intelligence · 2022Article
- Intimate Relationships and Coronary Heart Disease: Implications for Risk, Prevention, and Patient Management.Current cardiology reports · 2022Review
- Exploring a New Theoretical Model to Explain the Behavior of Medication Adherence.Pharmacy (Basel, Switzerland) · 2022Review
- Effectiveness of interventions targeting self-regulation to improve adherence to chronic disease medications: a meta-review of meta-analyses.Health psychology review · 2020Article
- Tailored Interventions to Improve Medication Adherence for Cardiovascular Diseases.Frontiers in pharmacology · 2020Review
- Co-occurring reasons for medication nonadherence within subgroups of patients with hyperlipidemia.Journal of behavioral medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
Abstract
Poor adherence to cardiovascular disease medications carries significant psychological, physical, and economic costs, including failure to achieve therapeutic goals, high rates of hospitalization and health care costs, and incidence of death. Despite much effort to design and evaluate adherence interventions, rates of adherence to cardiovascular-related medications have remained relatively stagnant. We identify two major reasons for this: First, interventions have not addressed the time-varying reasons for nonadherence, and 2nd, interventions have not explicitly targeted the self-regulatory processes involved in adherence behavior. Inclusion of basic and applied psychological science in intervention development may improve the efficacy and effectiveness of behavioral interventions to improve adherence. In this article, we use a taxonomy of time-based phases of adherence-including initiation, implementation, and discontinuation-as context within which to review illustrative studies of barriers to adherence, interventions to improve adherence, and self-regulatory processes involved in adherence. Finally, we suggest a framework to translate basic psychological science regarding self-regulation into multicomponent interventions that can address multiple and time-varying barriers to nonadherence across the three adherence phases. The field of psychology is essential to improving medication adherence and associated health outcomes, and concrete steps need to be taken to implement this knowledge in future interventions. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.